BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33781527)

  • 1. Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome?
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Al-Anazi A; Khan S; El-Solh H; Al-Seraihi A
    Transplant Cell Ther; 2021 Mar; 27(3):257.e1-257.e6. PubMed ID: 33781527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT.
    Rafii H; Volt F; Bierings M; Dalle JH; Ayas M; Rihani R; Faraci M; de Simone G; Sengeloev H; Passweg J; Cavazzana M; Costello R; Maertens J; Biffi A; Johansson JE; Montoro J; Guepin GR; Diaz MA; Sirvent A; Kenzey C; Rivera Franco MM; Cappelli B; Scigliuolo GM; Rocha V; Ruggeri A; Risitano A; De Latour RP; Gluckman E
    Transplant Cell Ther; 2024 May; 30(5):532.e1-532.e16. PubMed ID: 38452872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes.
    Fink O; Even-Or E; Avni B; Grisariu S; Zaidman I; Schejter YD; NaserEddin A; Najajreh M; Stepensky P
    Clin Transplant; 2023 Jan; 37(1):e14835. PubMed ID: 36259220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia.
    Bonfim C; Ribeiro L; Nichele S; Bitencourt M; Loth G; Koliski A; Funke VAM; Pilonetto DV; Pereira NF; Flowers MED; Velleuer E; Dietrich R; Fasth A; Torres-Pereira CC; Pedruzzi P; Eapen M; Pasquini R
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1257-1263. PubMed ID: 26976241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
    Thakar MS; Bonfim C; Sandmaier BM; O'Donnell P; Ribeiro L; Gooley T; Deeg HJ; Flowers ME; Pasquini R; Storb R; Woolfrey AE; Kiem HP
    Pediatr Hematol Oncol; 2012 Sep; 29(6):568-78. PubMed ID: 22839094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.
    Ebens CL; DeFor TE; Tryon R; Wagner JE; MacMillan ML
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):765-771. PubMed ID: 29203412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
    Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
    Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.
    Marsh RA; Rao MB; Gefen A; Bellman D; Mehta PA; Khandelwal P; Chandra S; Jodele S; Myers KC; Grimley M; Dandoy C; El-Bietar J; Kumar AR; Leemhuis T; Zhang K; Bleesing JJ; Jordan MB; Filipovich AH; Davies SM
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1460-70. PubMed ID: 25865646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
    Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases.
    Faraci M; Bagnasco F; Leoni M; Giardino S; Terranova P; Subissi L; Di Duca M; Di Martino D; Lanino E
    Biol Blood Marrow Transplant; 2018 May; 24(5):1088-1093. PubMed ID: 29292059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
    Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
    Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?
    Pichler H; Fritsch G; König M; Daxberger H; Glogova E; Pötschger U; Breuer S; Lawitschka A; Güclü ED; Karlhuber S; Holter W; Haas OA; Lion T; Matthes-Martin S
    Br J Haematol; 2016 Jun; 173(6):905-17. PubMed ID: 26996395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial.
    MacMillan ML; Auerbach AD; Davies SM; Defor TE; Gillio A; Giller R; Harris R; Cairo M; Dusenbery K; Hirsch B; Ramsay NK; Weisdorf DJ; Wagner JE
    Br J Haematol; 2000 Apr; 109(1):121-9. PubMed ID: 10848791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
    Kako S; Yamazaki H; Ohashi K; Ozawa Y; Ota S; Kanda Y; Maeda T; Kato J; Ishiyama K; Matsuoka KI; Miyamoto T; Iida H; Ikegame K; Fukuda T; Ichinohe T; Atsuta Y; Mori T;
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):445-450. PubMed ID: 31618688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Ringdén O
    Transplantation; 2001 Feb; 71(3):433-9. PubMed ID: 11233907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.